33,935 Shares in Bruker Corporation $BRKR Purchased by Groupe la Francaise

Groupe la Francaise bought a new stake in Bruker Corporation (NASDAQ:BRKR) during the 1st quarter, HoldingsChannel reports. The fund bought 33,935 shares of the medical research company’s stock, valued at approximately $1,222,000.

Other hedge funds have also added to or reduced their stakes in the company. Los Angeles Capital Management LLC acquired a new position in Bruker during the fourth quarter valued at approximately $26,000. Parallel Advisors LLC boosted its stake in Bruker by 121.0% in the fourth quarter. Parallel Advisors LLC now owns 875 shares of the medical research company’s stock valued at $41,000 after buying an additional 479 shares in the last quarter. Allworth Financial LP raised its stake in Bruker by 40.6% during the third quarter. Allworth Financial LP now owns 890 shares of the medical research company’s stock worth $29,000 after acquiring an additional 257 shares in the last quarter. Summit Securities Group LLC bought a new position in shares of Bruker in the fourth quarter worth about $50,000. Finally, Covestor Ltd boosted its stake in shares of Bruker by 304.6% in the 4th quarter. Covestor Ltd now owns 1,416 shares of the medical research company’s stock valued at $67,000 after purchasing an additional 1,066 shares in the last quarter. 79.52% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several equities research analysts recently issued reports on the stock. Guggenheim lifted their price target on shares of Bruker from $50.00 to $70.00 and gave the company a “buy” rating in a report on Monday, June 29th. Wall Street Zen upgraded shares of Bruker from a “hold” rating to a “buy” rating in a research report on Saturday, May 9th. JPMorgan Chase & Co. upped their price target on shares of Bruker from $55.00 to $65.00 and gave the stock an “overweight” rating in a report on Monday, June 8th. Leerink Partners increased their price target on Bruker from $60.00 to $70.00 and gave the company an “outperform” rating in a research note on Tuesday, July 7th. Finally, Stifel Nicolaus set a $45.00 price objective on Bruker in a report on Friday, May 8th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, six have given a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $56.79.

Bruker Stock Performance

NASDAQ BRKR opened at $62.84 on Friday. The company has a market capitalization of $9.57 billion, a price-to-earnings ratio of -261.83, a PEG ratio of 2.01 and a beta of 1.29. The company has a quick ratio of 0.72, a current ratio of 1.55 and a debt-to-equity ratio of 0.67. Bruker Corporation has a twelve month low of $28.53 and a twelve month high of $65.30. The stock has a fifty day simple moving average of $58.15 and a 200 day simple moving average of $46.66.

Bruker (NASDAQ:BRKR) last released its quarterly earnings results on Wednesday, May 6th. The medical research company reported $0.31 EPS for the quarter, beating analysts’ consensus estimates of $0.23 by $0.08. The firm had revenue of $823.40 million for the quarter, compared to analyst estimates of $795.62 million. Bruker had a positive return on equity of 11.60% and a negative net margin of 0.65%.The business’s revenue was up 2.7% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.47 EPS. Bruker has set its FY 2026 guidance at 2.100-2.150 EPS. Sell-side analysts expect that Bruker Corporation will post 2.12 EPS for the current year.

Bruker Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, July 7th. Shareholders of record on Monday, June 22nd were given a dividend of $0.05 per share. This represents a $0.20 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date of this dividend was Monday, June 22nd. Bruker’s dividend payout ratio is currently -83.33%.

Bruker Company Profile

Bruker Corporation, founded in 1960 by physicist Günther Laukien and headquartered in Billerica, Massachusetts, is a leading developer and manufacturer of high-performance scientific instruments and analytical solutions. The company designs systems that enable molecular and materials research across academic, governmental, and industrial laboratories.

Bruker’s product portfolio encompasses nuclear magnetic resonance (NMR) spectrometers for molecular structure and dynamics studies, mass spectrometry platforms for proteomics and metabolomics, X-ray diffraction and scattering instruments for crystallography and materials characterization, atomic force and scanning probe microscopes for nanoscale surface analysis, as well as preclinical imaging systems such as micro-CT and MRI scanners.

In addition to hardware, Bruker provides software suites, applications support, training services, and long-term maintenance agreements to ensure optimal instrument performance.